If you are looking for a step-by-step discussion on some of the data pain points of clinical trials, then the episode of Data in Biotech with Miguel Cacho Soblechero is a great starting point. Looking at every stage, we sat down to discuss the challenges of clinical trials and the direction data ...

With a rich background in both academia and industry, Michelle Wiest provided fascinating insight into her current role assisting with the development and marketing of early blood-based cancer diagnostics. The conversation covered a lot of ground, from a whistlestop tour of her career to how she ...

One of the great things about looking at Data in Biotech is the variety within the industry. Having looked at regulation, digital twins, and real-human data, our conversation with Markus Gershater, co-founder at Synthace looks at the design of experiments and how this influences the management of ...

We are thrilled to have recently launched our new podcast ‘Data in Biotech’ with some of the leading thinkers in the field giving their take on industry challenges and trends. To accompany each podcast, this blog series will pick out the highlights of each episode and cover additional topics using ...

On this episode of Data in Biotech, we’re excited to be joined by Pradeep Ravindra, Associate Director, Data Analytics, Manufacturing from Lyell Immunopharma.

On this episode of Data in Biotech, we’re excited to be joined by Markus Gershater, Chief Scientific Officer and CoFounder of Synthace - a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress.

On this episode of Data in Biotech, we’re excited to be joined by Michelle Wiest, Director of IVD Biostatistics at Freenome - a high-growth biotech company that creates tools to help prevent, detect, and treat disease.

It’s an arbitrary measurement, but the ‘first 100 days’ has become a benchmark for judging the success of new initiatives, such as a data platform. Originally used to gauge the success of new U.S. Presidents, the first 100 days are now widely used as a yardstick in businesses to measure upfront ...

You wouldn’t take on a new employee, pay them a salary and then ask them to sit back and take it easy. Yet, many enterprises do this with their data. They invest in data management and storage to meet regulatory requirements, but it sits within the organization underutilized and becomes ‘lazy’ data.